This signal was shared with ulcerative colitis (UC, PP > 95.3%), systemic lupus erythematosus (SLE, PP > 82.6%) and various cell surface markers of different immune cell populations, including FCGR2A (CD32) (Fig. 4). This evidence concerns the gene FCGR2B and systemic lupus erythematosus.